Search results
Results From The WOW.Com Content Network
Roche inks a deal with Foundation Medicine to acquire the remaining shares of Foundation Medicine, not already owned by it for a total consideration of $2.4 billion.
Foundation Medicine was founded in Cambridge, Massachusetts. [3] The company was conceived after Broad Institute researchers Levi Garraway and Matthew Meyerson published a 2007 paper detailing a method for large-panel testing of 238 DNA mutations. [4] Foundation Medicine launched in 2010 with a $25 million Series A financing led by Third Rock ...
Foundation Medicine Prices Initial Public Offering of Common Stock CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced the pricing of its initial public offering of ...
As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion. As of 2019, it is a Fortune 1000 corporation. [3]
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Mind Medicine (NASDAQ: MNMD) stock is posting big gains in Tuesday's trading. The biotech company's share price was up 8.7% as of 2 p.m. ET despite a 0.8% pullback for the S&P 500 index and a 1.5% ...
The Trust's purpose was to use profits from the Wellcome Foundation to advance research in medicine and medical history. In 1955, Sir Henry Dale , one of the Trust's original trustees and its chair for 21 years, and William N. Creasy, president and chair of Burroughs Wellcome Co. USA, created a U.S. extension of the Wellcome Trust called the ...
Science & Tech. Shopping. Sports